Promotions & Moves

Jubilant Therapeutics Appoints President and CEO

Syed Kazmi's accomplished career includes 25 years in M&A, licensing, strategic collaborations, and R&D in specialty biotech and large pharma

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Jubilant Life Sciences Ltd. has appointed Dr. Syed Kazmi, PhD, MBA, as President and Chief Executive Officer of its new innovative biopharmaceutical company in the U.S., Jubilant Therapeutics Inc.  Dr. Kazmi joins the company from Novartis Pharmaceuticals, where he was Vice President, Global Head of Business Development & Licensing for Oncology.   Earlier this year, Jubilant Life Sciences spun off certain innovation assets that are in various stages of discovery and development into Jubila...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters